Does liraglutide reduce hospitalization risk compared with glimepiride in people with type 2 diabetes on metformin?

In GRADE participants with type 2 diabetes on metformin, time to first hospitalization did not differ overall by glucose-lowering drug; liraglutide modestly reduced subsequent hospitalization risk versus glimepiride on assigned treatment.

Secondary analysis of a randomised trial · Diabetes Care 2025

Reference: Hsia DS, Younes N, Ghosh A. Diabetes Care. 2025. PMID: 40424051. https://pubmed.ncbi.nlm.nih.gov/40424051/

AI-narrated episode. For healthcare professionals; educational only and not medical advice.

Hormone Insight: https://hormoneinsight.com/

iPhone/iPad app: https://apps.apple.com/sa/app/hormone-insight/id6749515856

Android app: https://play.google.com/store/apps/details?id=com.fahadwali78.hormoneinsightmobile&hl=en